Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a novel way to engineer yeast (Saccharomyces cerevisiae) to create microbial communities that can perform complex tasks and self-regulate their composition in response to external signals.
Reprogrammed yeast cells enhance drug delivery precision
